首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1746598

日本药物筛选市场报告（按产品和服务、样本类型、最终用户和地区划分）2025 年至 2033 年

Japan Drug Screening Market Report by Product and Service, Sample Type, End User, and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 119 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2024年，日本药物筛检市场规模达4.063亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到13.533亿美元，2025-2033年期间的复合年增长率（CAGR）为14.3%。推动该市场发展的几个重要因素包括毒贩和本地毒贩的日益增多、药物滥用案件的激增以及虚拟货币的使用日益增多。

药物筛检涉及采集和检查个别血液、尿液、头髮或唾液，以识别其中是否存在提示药物使用的物质和化学物质。该过程涵盖多种检测方法，包括酶联免疫吸附测定 (IAs)、气相层析 (GC) 和液相层析/质谱 (LC/MS)。当初步结果呈阳性时，LC/MS 被认为是一种高效且高精度的确认方法。其主要目的是检测药物的合法和非法使用，涵盖可卡因、海洛因和 3,4-亚甲基二氧基甲基安非他命 (MDMA) 等非法物质。此外，它还用于识别各种处方药的滥用情况，例如药物滥用或过量使用。药物筛检在临床试验中对评估新药的有效性和安全性起着至关重要的作用。此外，它也是法律诉讼的重要组成部分，服务于刑事执法目的。此外，它还有助于评估接受鸦片类药物治疗的患者滥用药物的可能性和依从性。

日本药物筛选市场趋势：

日本药物筛检市场目前正经历显着成长，这受到多种因素的推动。其中最重要的因素是药物筛检需求的不断增长，这得益于其准确性和快速交付结果的优势，使其成为各种应用的理想选择。此外，随着社会努力应对成瘾及其后果的挑战，药物滥用案件的增加是市场扩张的关键驱动力。另一个促进市场成长的因素是，越来越多人将药物视为应对压力、焦虑和生活困境的机制，进一步凸显了有效的药物筛检的重要性。此外，政府机构也发挥关键作用，他们启动定期路边唾液筛检，以检测吸毒驾驶员，并启动药物滥用和成瘾项目，以满足吸毒者的需求。此外，由于虚拟货币为买卖双方提供了匿名性，毒贩和当地经销商的存在也推动了市场的扩张。这些因素将共同促成日本药物筛检市场在预测期内的乐观前景。

日本药物筛选市场细分：

产品和服务洞察：

装置
- 免疫分析仪
- 色谱仪器
- 呼吸分析仪
快速检测设备
- 尿液检测设备
- 口腔液体检测设备
耗材
- 检测试剂盒
- 样品收集杯
- 校准器和控制器
- 其他的
实验室服务

样本类型洞察：

尿液样本
呼吸样本
口腔液体样本
头髮样本
其他的

最终用户洞察：

医院
药物检测实验室
工作场所
药物治疗中心
疼痛管理中心
个人用户
刑事司法系统和执法机构

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争指标和公司评估象限等竞争分析。此外，报告还提供了所有主要公司的详细资料。

本报告回答的关键问题：

日本药物筛选市场迄今表现如何？未来几年将如何表现？
COVID-19 对日本药物筛选市场有何影响？
日本药物筛选市场依产品和服务的划分是怎样的？
根据样本类型，日本药物筛选市场是如何分類的？
根据最终用户，日本药物筛选市场是如何分類的？
日本药物筛选市场的价值链分为哪些阶段？
日本药物筛选的关键驱动因素和挑战是什么？
日本药物筛选市场的结构是怎么样的？主要参与者是谁？
日本药物筛选市场的竞争程度如何？

本报告回答的关键问题：

日本药物筛选市场迄今表现如何？未来几年将如何表现？
COVID-19 对日本药物筛选市场有何影响？
日本药物筛选市场依产品和服务的划分是怎样的？
根据样本类型，日本药物筛选市场是如何分類的？
根据最终用户，日本药物筛选市场是如何分類的？
日本药物筛选市场的价值链分为哪些阶段？
日本药物筛选的关键驱动因素和挑战是什么？
日本药物筛选市场的结构是怎么样的？主要参与者是谁？
日本药物筛选市场的竞争程度如何？

装置
- 概述
- 市场区隔
  - 免疫分析仪
  - 色谱仪器
  - 呼吸分析仪
快速检测设备
- 概述
- 市场区隔
  - 尿液检测设备
  - 口腔液体检测设备
耗材
- 概述
- 市场区隔
  - 检测试剂盒
  - 样品收集杯
  - 校准器和控制器
  - 其他的
实验室服务
- 概述

第七章：日本药物筛选市场-细分：依样本类型

尿液样本
- 概述
呼吸样本
- 概述
口腔液体样本
- 概述
头髮样本
- 概述
其他的

第 8 章：日本药物筛选市场 - 细分：按最终用户

医院
- 概述
药物检测实验室
- 概述
工作场所
- 概述
药物治疗中心
- 概述
疼痛管理中心
- 概述
个人用户
- 概述
刑事司法系统和执法机构
- 概述

第九章：日本药物筛选市场－竞争格局

概述
市场结构
市场参与者定位
最佳获胜策略
竞争仪錶板
公司评估象限

第十章：关键参与者简介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 11 章：日本药物筛选市场 - 产业分析

驱动因素、限制因素和机会
- 概述
- 驱动程式
- 限制
- 机会
波特五力分析
- 概述
- 买家的议价能力
- 供应商的议价能力
- 竞争程度
- 新进入者的威胁
- 替代品的威胁
价值链分析

第 12 章：附录

简介目录

Product Code: SR112025A19553

Japan drug screening market size reached USD 406.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,353.3 Million by 2033, exhibiting a growth rate (CAGR) of 14.3% during 2025-2033. The market is being propelled by several significant factors, including the escalating presence of drug traffickers and local dealers, a surge in substance abuse cases, and the growing utilization of virtual currencies.

Drug screening involves the procedure of collecting and examining an individual's blood, urine, hair, or saliva to identify the presence of substances and chemicals indicative of drug use. This process encompasses a wide array of testing methods, including enzyme immunoassays (IAs), gas chromatography (GC), and liquid chromatography/mass spectrometry (LC/MS), which is considered a superior and highly precise confirmation test utilized when initial results show positive. Its primary purpose is to detect both the legitimate and illegitimate use of drugs, spanning illegal substances like cocaine, heroin, and 3,4-Methylenedioxymethamphetamine (MDMA). Additionally, it is employed to identify the misuse of various prescription medications when they are consumed differently or in excessive quantities. Drug screening plays a crucial role in clinical trials for evaluating the effectiveness and safety of novel drugs. Moreover, it is an essential component in legal proceedings, serving the purposes of criminal law enforcement. Furthermore, it aids in assessing the potential for abuse and adherence among patients receiving opioid therapy.

Japan Drug Screening Market Trends:

The Japan drug screening market is currently experiencing significant growth driven by a multitude of influential factors. Foremost among these factors is the rising demand for drug screening due to its accuracy and the rapid delivery of results, making it an appealing choice for various applications. Moreover, the increase in cases of substance abuse is a key driver of market expansion, as societies grapple with the challenges of addiction and its consequences. Another factor contributing to the market's growth is the growing prevalence of drug use as a coping mechanism for stress, anxiety, and life's hardships, further emphasizing the need for effective drug screening. Additionally, government agencies are also playing a pivotal role by initiating regular roadside oral fluid screening to detect drug-impaired drivers and launching substance abuse and addiction programs to address the needs of addicts. Furthermore, the presence of drug traffickers and local dealers, facilitated by the use of virtual currencies that offer anonymity to buyers and sellers, is supporting the market's expansion. These factors will collectively contribute to the positive outlook for the drug screening market in Japan over the forecasted period.

Japan Drug Screening Market Segmentation:

Product and Service Insights:

Equipment
- Immunoassay Analyzers
- Chromatography Instruments
- Breath Analyzers
Rapid Testing Devices
- Urine Testing Devices
- Oral Fluid Testing Devices
Consumables
- Assay Kits
- Sample Collection Cups
- Calibrators and Controls
- Others
Laboratory Services

Sample Type Insights:

Urine Samples
Breath Samples
Oral Fluid Samples
Hair Samples
Others

End User Insights:

Hospitals
Drug Testing Laboratories
Workplaces
Drug Treatment Centers
Pain Management Centers
Personal Users
Criminal Justice System and Law Enforcement Agencies

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan drug screening market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan drug screening market?
What is the breakup of the Japan drug screening market on the basis of product and service?
What is the breakup of the Japan drug screening market on the basis of sample type?
What is the breakup of the Japan drug screening market on the basis of end user?
What are the various stages in the value chain of the Japan drug screening market?
What are the key driving factors and challenges in the Japan drug screening?
What is the structure of the Japan drug screening market and who are the key players?
What is the degree of competition in the Japan drug screening market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Drug Screening Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Drug Screening Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Drug Screening Market - Breakup by Product and Service

6.1 Equipment
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Immunoassay Analyzers
  - 6.1.3.2 Chromatography Instruments
  - 6.1.3.3 Breath Analyzers
- 6.1.4 Market Forecast (2025-2033)
6.2 Rapid Testing Devices
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Urine Testing Devices
  - 6.2.3.2 Oral Fluid Testing Devices
- 6.2.4 Market Forecast (2025-2033)
6.3 Consumables
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Segmentation
  - 6.3.3.1 Assay Kits
  - 6.3.3.2 Sample Collection Cups
  - 6.3.3.3 Calibrators and Controls
  - 6.3.3.4 Others
- 6.3.4 Market Forecast (2025-2033)
6.4 Laboratory Services
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)

7 Japan Drug Screening Market - Breakup by Sample Type

7.1 Urine Samples
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Breath Samples
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Oral Fluid Samples
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Hair Samples
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2019-2024)
- 7.5.2 Market Forecast (2025-2033)

8 Japan Drug Screening Market - Breakup by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Drug Testing Laboratories
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Workplaces
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Drug Treatment Centers
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Pain Management Centers
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2019-2024)
- 8.5.3 Market Forecast (2025-2033)
8.6 Personal Users
- 8.6.1 Overview
- 8.6.2 Historical and Current Market Trends (2019-2024)
- 8.6.3 Market Forecast (2025-2033)
8.7 Criminal Justice System and Law Enforcement Agencies
- 8.7.1 Overview
- 8.7.2 Historical and Current Market Trends (2019-2024)
- 8.7.3 Market Forecast (2025-2033)

9 Japan Drug Screening Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Drug Screening Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis